Latest patient health care News
Takeda’s Adzynma approved by MHRA for rare blood clotting disorder cTTP
The enzyme replacement therapy is now the first…
Understanding Common Defects in Tablets: A Quality Perspective
In pharmaceutical manufacturing, tablet defects are critical indicators…
